drugset

drugset / Trial / NCT00351052

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

NCT00351052 ↗

Phase 3 Completed 184 enrolled Novartis

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will investigate the steroid sparing effect of pimecrolimus cream 1% in pediatric atopic dermatitis

Timeline

Start: 2001-12
Primary completion: —
Completion: 2004-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pimecrolimus	Small molecule	1 %	—

Indications